Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fareed Ahmad

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Clinical, Cosmetic and Investigational Dentistry|October 21, 2024
A Retrospective Evaluation of Mandibular Fracture in Kabul, AfghanistanShahab Uddin Ahmadi, Yahya Fayaz, Said Ahmad Sorosh Miri, et al.
Phytotherapy Research : PTR|April 6, 2026
Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell LymphomaShilpa Kuttikrishnan, Muhammad Suleman, Fareed Ahmad, et al.
Seminars in Cancer Biology|July 28, 2020
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseasesAbdul Q Khan, Fareed Ahmad, Syed Shadab Raza, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 12, 2024
Targeting of S-phase kinase associated protein 2 stabilized tumor suppressors leading to apoptotic cell death in squamous skin cancer cellsAbdul Q Khan, Maha Al-Tamimi, Rasheeda Anver, et al.
Cell Biology International|August 20, 2025
Targeting mTOR and Its Associated Signaling to Induce Cell Death in Breast Cancer Stem CellsKirti S Prabhu, Zahwa Mariyam, Syed A Rahman, et al.
International Immunopharmacology|August 26, 2023
Azithromycin downregulates ICOS (CD278) and OX40 (CD134) expression and mTOR activity of TCR-activated T cells to inhibit proliferationAbdul Wahid Ansari, Fareed Ahmad, Thesni Raheed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
AIDS (London, England)|October 19, 2016
LILRA3 deletion is a genetic risk factor of HIV infectionGerrit Ahrenstorf, Hui Zhi Low, Katja Kniesch, et al.
Toxicology and Applied Pharmacology|April 5, 2026
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axisShilpa Kuttikrishnan, Rasheeda Anver, Fareed Ahmad, et al.
Frontiers in Immunology|August 30, 2024
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotypeAbdul Wahid Ansari, Manju Nidagodu Jayakumar, Fareed Ahmad, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Clinical, Cosmetic and Investigational Dentistry|October 21, 2024
A Retrospective Evaluation of Mandibular Fracture in Kabul, AfghanistanShahab Uddin Ahmadi, Yahya Fayaz, Said Ahmad Sorosh Miri, et al.
Phytotherapy Research : PTR|April 6, 2026
Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell LymphomaShilpa Kuttikrishnan, Muhammad Suleman, Fareed Ahmad, et al.
Seminars in Cancer Biology|July 28, 2020
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseasesAbdul Q Khan, Fareed Ahmad, Syed Shadab Raza, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 12, 2024
Targeting of S-phase kinase associated protein 2 stabilized tumor suppressors leading to apoptotic cell death in squamous skin cancer cellsAbdul Q Khan, Maha Al-Tamimi, Rasheeda Anver, et al.
Cell Biology International|August 20, 2025
Targeting mTOR and Its Associated Signaling to Induce Cell Death in Breast Cancer Stem CellsKirti S Prabhu, Zahwa Mariyam, Syed A Rahman, et al.
International Immunopharmacology|August 26, 2023
Azithromycin downregulates ICOS (CD278) and OX40 (CD134) expression and mTOR activity of TCR-activated T cells to inhibit proliferationAbdul Wahid Ansari, Fareed Ahmad, Thesni Raheed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
AIDS (London, England)|October 19, 2016
LILRA3 deletion is a genetic risk factor of HIV infectionGerrit Ahrenstorf, Hui Zhi Low, Katja Kniesch, et al.
Toxicology and Applied Pharmacology|April 5, 2026
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axisShilpa Kuttikrishnan, Rasheeda Anver, Fareed Ahmad, et al.
Frontiers in Immunology|August 30, 2024
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotypeAbdul Wahid Ansari, Manju Nidagodu Jayakumar, Fareed Ahmad, et al.
Pageof 9